Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s13139-013-0244-2.

Title:
Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT | Nuclear Medicine and Molecular Imaging
Description:
The aim of this study was to evaluate the characteristics of PET and CT features of mediastinal metastatic lymph nodes on F-18 FDG PET/CT and to determine the diagnostic criteria in nodal staging of non-small cell lung cancer. One hundred four non-small cell lung cancer patients who had preoperative F-18 FDG PET/CT were included. For quantitative analysis, the maximum SUV of the primary tumor, maximum SUV of the lymph nodes (SUVmax), size of the lymph nodes, and average Hounsfield units (aHUs) and maximum Hounsfield units (mHUs) of the lymph nodes were measured. The SUVmax, SUV ratio of the lymph node to blood pool (LN SUV/blood pool SUV), SUV ratio of the lymph node to primary tumor (LN SUV/primary tumor SUV), size, aHU, and mHU were compared between the benign and malignant lymph nodes. Among 372 dissected lymph node stations that were pathologically diagnosed after surgery, 49 node stations were malignant and 323 node stations benign. SUVmax, LN SUV/blood pool SUV, and size were significantly different between the malignant and benign lymph node stations (P < 0.0001). However, there was no significant difference in LN SUV/primary tumor SUV (P = 0.18), mHU (P = 0.42), and aHU (P = 0.98). Using receiver-operating characteristic curve analyses, there was no significant difference among these three variables (SUVmax, LN SUV/blood pool SUV, and size). The optimal cutoff values were 2.9 for SUVmax, 1.4 for LN SUV/blood pool SUV, and 5 mm for size. When the cutoff value of SUVmax ≥2.9 and size ≥5 mm were used in combination, the positive predictive value was 44.2 %, and the negative predictive value was 90.9 %. When we evaluated the results based on the histology of the primary tumor, the negative predictive value was 92.3 % in adenocarcinoma (cutoff values of SUVmax ≥2.3 and size ≥5 mm) and 97.2 % in squamous cell carcinoma (cutoff values of SUVmax ≥3.6 and size ≥8 mm), separately. In the lymph node staging of non-small cell lung cancer, SUVmax, LN SUV/blood pool SUV, and size show statistically significant differences between malignant and benign lymph nodes. These variables can be used to differentiate malignant from benign lymph nodes. The combination of the SUVmax and size of lymph node might have a good negative predictive value.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Cryptocurrency
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, cancer, lung, lymph, google, scholar, pubmed, cell, staging, nonsmall, node, nodes, cas, petct, suv, imaging, suvmax, fdg, size, mediastinal, tumor, pet, tomography, med, kim, lee, nonsmallcell, patients, primary, pool, benign, privacy, cookies, content, research, preoperative, park, suvblood, malignant, carcinoma, access, ffdg, metastasis, eur, surg, radiology, nucl, publish, search, nuclear,

Topics {✒️}

dual-time-point fdg pet/ct dual-modality pet/ct tomography month download article/chapter 18f-fdg pet-ct scan small-cell lung cancer small-cell lung cancer sang kyun bae revised tumor-node-metastasis classification f-18 fdg pet/ct kr/ncic/cics_f/02/022/index 18f-fdg pet/ct integrated fdg-pet/ct 1990s meta-analytic comparison related subjects integrated positron-emission tomography presurgical detection—prospective study1 inflammatory lung disease 18f-fdg imaging article nuclear medicine full article pdf fdg pet/ct fdg-pet scan lung cancer staging fdg pet imaging squamous cell carcinoma privacy choices/manage cookies national cancer center mediastinal lymph nodes regional lymph nodes nonsmall cell carcinoma pet/ct evaluation1 postoperative survival based lymph node metastasis primary tumor suv molecular imaging aims lymph node staging locoregional lymph nodes intrathoracic lymph nodes article lee benign lymph nodes magnetic resonance imaging positron emission tomography clin nucl med european economic area blood pool german consensus conference rev pneumol clin opportunities—changing algorithm inje university college lung cancer

Questions {❓}

  • Dual-time-point FDG PET/CT: is it useful for lymph node staging in patients with non-small-cell lung cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT
         description:The aim of this study was to evaluate the characteristics of PET and CT features of mediastinal metastatic lymph nodes on F-18 FDG PET/CT and to determine the diagnostic criteria in nodal staging of non-small cell lung cancer. One hundred four non-small cell lung cancer patients who had preoperative F-18 FDG PET/CT were included. For quantitative analysis, the maximum SUV of the primary tumor, maximum SUV of the lymph nodes (SUVmax), size of the lymph nodes, and average Hounsfield units (aHUs) and maximum Hounsfield units (mHUs) of the lymph nodes were measured. The SUVmax, SUV ratio of the lymph node to blood pool (LN SUV/blood pool SUV), SUV ratio of the lymph node to primary tumor (LN SUV/primary tumor SUV), size, aHU, and mHU were compared between the benign and malignant lymph nodes. Among 372 dissected lymph node stations that were pathologically diagnosed after surgery, 49 node stations were malignant and 323 node stations benign. SUVmax, LN SUV/blood pool SUV, and size were significantly different between the malignant and benign lymph node stations (P < 0.0001). However, there was no significant difference in LN SUV/primary tumor SUV (P = 0.18), mHU (P = 0.42), and aHU (P = 0.98). Using receiver-operating characteristic curve analyses, there was no significant difference among these three variables (SUVmax, LN SUV/blood pool SUV, and size). The optimal cutoff values were 2.9 for SUVmax, 1.4 for LN SUV/blood pool SUV, and 5 mm for size. When the cutoff value of SUVmax ≥2.9 and size ≥5 mm were used in combination, the positive predictive value was 44.2 %, and the negative predictive value was 90.9 %. When we evaluated the results based on the histology of the primary tumor, the negative predictive value was 92.3 % in adenocarcinoma (cutoff values of SUVmax ≥2.3 and size ≥5 mm) and 97.2 % in squamous cell carcinoma (cutoff values of SUVmax ≥3.6 and size ≥8 mm), separately. In the lymph node staging of non-small cell lung cancer, SUVmax, LN SUV/blood pool SUV, and size show statistically significant differences between malignant and benign lymph nodes. These variables can be used to differentiate malignant from benign lymph nodes. The combination of the SUVmax and size of lymph node might have a good negative predictive value.
         datePublished:2013-11-06T00:00:00Z
         dateModified:2013-11-06T00:00:00Z
         pageStart:41
         pageEnd:46
         sameAs:https://doi.org/10.1007/s13139-013-0244-2
         keywords:
            F-18 FDG
            PET/CT
            Non-small cell lung cancer
            Mediastinal lymph nodes
            Nuclear Medicine
            Imaging / Radiology
            Orthopedics
            Cardiology
            Oncology
         image:
         isPartOf:
            name:Nuclear Medicine and Molecular Imaging
            issn:
               1869-3482
               1869-3474
            volumeNumber:48
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ah Young Lee
               affiliation:
                     name:Inje University College of Medicine
                     address:
                        name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Su Jung Choi
               affiliation:
                     name:Inje University College of Medicine
                     address:
                        name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kyung Pyo Jung
               affiliation:
                     name:Inje University College of Medicine
                     address:
                        name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ji Sun Park
               affiliation:
                     name:Inje University College of Medicine
                     address:
                        name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Seok Mo Lee
               affiliation:
                     name:Inje University College of Medicine
                     address:
                        name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sang Kyun Bae
               affiliation:
                     name:Inje University College of Medicine
                     address:
                        name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT
      description:The aim of this study was to evaluate the characteristics of PET and CT features of mediastinal metastatic lymph nodes on F-18 FDG PET/CT and to determine the diagnostic criteria in nodal staging of non-small cell lung cancer. One hundred four non-small cell lung cancer patients who had preoperative F-18 FDG PET/CT were included. For quantitative analysis, the maximum SUV of the primary tumor, maximum SUV of the lymph nodes (SUVmax), size of the lymph nodes, and average Hounsfield units (aHUs) and maximum Hounsfield units (mHUs) of the lymph nodes were measured. The SUVmax, SUV ratio of the lymph node to blood pool (LN SUV/blood pool SUV), SUV ratio of the lymph node to primary tumor (LN SUV/primary tumor SUV), size, aHU, and mHU were compared between the benign and malignant lymph nodes. Among 372 dissected lymph node stations that were pathologically diagnosed after surgery, 49 node stations were malignant and 323 node stations benign. SUVmax, LN SUV/blood pool SUV, and size were significantly different between the malignant and benign lymph node stations (P < 0.0001). However, there was no significant difference in LN SUV/primary tumor SUV (P = 0.18), mHU (P = 0.42), and aHU (P = 0.98). Using receiver-operating characteristic curve analyses, there was no significant difference among these three variables (SUVmax, LN SUV/blood pool SUV, and size). The optimal cutoff values were 2.9 for SUVmax, 1.4 for LN SUV/blood pool SUV, and 5 mm for size. When the cutoff value of SUVmax ≥2.9 and size ≥5 mm were used in combination, the positive predictive value was 44.2 %, and the negative predictive value was 90.9 %. When we evaluated the results based on the histology of the primary tumor, the negative predictive value was 92.3 % in adenocarcinoma (cutoff values of SUVmax ≥2.3 and size ≥5 mm) and 97.2 % in squamous cell carcinoma (cutoff values of SUVmax ≥3.6 and size ≥8 mm), separately. In the lymph node staging of non-small cell lung cancer, SUVmax, LN SUV/blood pool SUV, and size show statistically significant differences between malignant and benign lymph nodes. These variables can be used to differentiate malignant from benign lymph nodes. The combination of the SUVmax and size of lymph node might have a good negative predictive value.
      datePublished:2013-11-06T00:00:00Z
      dateModified:2013-11-06T00:00:00Z
      pageStart:41
      pageEnd:46
      sameAs:https://doi.org/10.1007/s13139-013-0244-2
      keywords:
         F-18 FDG
         PET/CT
         Non-small cell lung cancer
         Mediastinal lymph nodes
         Nuclear Medicine
         Imaging / Radiology
         Orthopedics
         Cardiology
         Oncology
      image:
      isPartOf:
         name:Nuclear Medicine and Molecular Imaging
         issn:
            1869-3482
            1869-3474
         volumeNumber:48
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ah Young Lee
            affiliation:
                  name:Inje University College of Medicine
                  address:
                     name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Su Jung Choi
            affiliation:
                  name:Inje University College of Medicine
                  address:
                     name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kyung Pyo Jung
            affiliation:
                  name:Inje University College of Medicine
                  address:
                     name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ji Sun Park
            affiliation:
                  name:Inje University College of Medicine
                  address:
                     name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Seok Mo Lee
            affiliation:
                  name:Inje University College of Medicine
                  address:
                     name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sang Kyun Bae
            affiliation:
                  name:Inje University College of Medicine
                  address:
                     name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nuclear Medicine and Molecular Imaging
      issn:
         1869-3482
         1869-3474
      volumeNumber:48
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Inje University College of Medicine
      address:
         name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
         type:PostalAddress
      name:Inje University College of Medicine
      address:
         name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
         type:PostalAddress
      name:Inje University College of Medicine
      address:
         name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
         type:PostalAddress
      name:Inje University College of Medicine
      address:
         name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
         type:PostalAddress
      name:Inje University College of Medicine
      address:
         name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
         type:PostalAddress
      name:Inje University College of Medicine
      address:
         name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ah Young Lee
      affiliation:
            name:Inje University College of Medicine
            address:
               name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
               type:PostalAddress
            type:Organization
      name:Su Jung Choi
      affiliation:
            name:Inje University College of Medicine
            address:
               name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
               type:PostalAddress
            type:Organization
      name:Kyung Pyo Jung
      affiliation:
            name:Inje University College of Medicine
            address:
               name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
               type:PostalAddress
            type:Organization
      name:Ji Sun Park
      affiliation:
            name:Inje University College of Medicine
            address:
               name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
               type:PostalAddress
            type:Organization
      name:Seok Mo Lee
      affiliation:
            name:Inje University College of Medicine
            address:
               name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
               type:PostalAddress
            type:Organization
      name:Sang Kyun Bae
      affiliation:
            name:Inje University College of Medicine
            address:
               name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
      name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
      name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
      name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
      name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
      name:Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(118)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.07s.